Abstract:<p>The susceptibility and severity of periodontal diseases is made more severe by diabetes, with the impact on the disease process inversely proportional to the level of glycemic control. Although type 1 diabetes mellitus and type 2 diabetes mellitus have different etiologies, and their impact on bone is not identical, they share many of the same complications. Studies in animals and humans agree that both forms of diabetes increase inflammatory events in periodontal tissue, impair new bone formation, and increase expression of RANKL in response to bacterial challenge. High levels of glucose, reactive oxygen species, and advanced glycation end‐products are found in the periodontium of diabetic individuals and lead to increased activation of nuclear factor‐kappa B and expression of inflammatory cytokines such as tumor necrosis factor and interleukin‐1. Studies in animals, moreover, suggest that there are multiple cell types in periodontal tissues that are affected by diabetes, including leukocytes, vascular cells, mesenchymal stem cells, periodontal ligament fibroblasts, osteoblasts, and osteocytes. The etiology of periodontal disease involves the host response to bacterial challenge that is affected by diabetes, which increases the expression of RANKL and reduces coupled bone formation. In addition, the inflammatory response also modifies the oral microbiota to render it more pathogenic, as demonstrated by increased inflammation and bone loss in animals where bacteria are transferred from diabetic donors to germ‐free hosts compared with transfer from normoglycemic donors. This approach has the advantage of not relying upon limited knowledge of the specific bacterial taxa to determine pathogenicity, and examines the overall impact of the microbiota rather than the presumed pathogenicity of a few bacterial groups. Thus, animal studies have provided new insights into pathogenic mechanisms that identify cause‐and‐effect relationships that are difficult to perform in human studies.</p>

Extracellular vesicles—Potential link between periodontal disease and diabetic complications

Integrative biology of extracellular vesicles in diabetes mellitus and diabetic complications

Microbial‐ and host immune cell‐derived extracellular vesicles in the pathogenesis and therapy of periodontitis: A narrative review

Endothelial extracellular vesicles: their possible function and clinical significance in diabetic vascular complications

Multi-prospects of bacterial extracellular vesicles in immune modulation, inflammation regulation, and periodontitis treatment

Extracellular vesicle-mediated intercellular and interorgan crosstalk of pancreatic islet in health and diabetes

Emerging role of extracellular vesicles in diabetic retinopathy

The bidirectional biological interplay between microbiome and viruses in periodontitis and type-2 diabetes mellitus

Extracellular Vesicles for Dental Pulp and Periodontal Regeneration

[Advances in Research on the Mechanism of Association Between Periodontitis and Diabetes Mellitus].

Extracellular vesicles derived from different sources play various roles in diabetic retinopathy

Clinical Potential of Extracellular Vesicles in Type 2 Diabetes

Link between periodontitis and diabetic retinopathy: Inflammatory pathways and clinical implications

Extracellular vesicles in obesity and diabetes mellitus

Extracellular vesicles in diabetes mellitus induce alterations in endothelial cell morphology and migration

Extracellular vesicles as signaling mediators in type 2 diabetes mellitus

Diabetes mellitus promotes susceptibility to periodontitis-novel insight into the molecular mechanisms

Investigating the Interplay: Periodontal Disease and Type 1 Diabetes Mellitus-A Comprehensive Review of Clinical Studies

The impact of diabetes on periodontal diseases

Pathogenic mechanisms, diagnostic, and therapeutic potential of microvesicles in diabetes and its complications

Interrelationship between diabetes and periodontitis: Role of hyperlipidemia